Crooke Cell Adenoma: Is Its Aggressiveness Overestimated? Evidence From a Single‐Centre Experience
Our findings suggest that CCAs may not be as aggressive as previously assumed with respect to biochemical remission and recurrence rates. Nonetheless, their larger tumour size, higher proliferative index, and increased likelihood of residual disease underscore the importance of careful long-term follow-up. Further multicenter studies are warranted to better characterize the clinical course of CCAs.
Authors
- Lala Soltanova (ORCID: https://orcid.org/0000-0002-4420-4721)
- Nurperi Gazioğlu (ORCID: https://orcid.org/0000-0001-7785-8628)
- Nil Çomunoğlu (ORCID: https://orcid.org/0000-0002-2319-1757)
- İlkin Muradov (ORCID: https://orcid.org/0000-0002-1906-0535)
- Sümeyye AKPINAR (ORCID: https://orcid.org/0000-0001-6211-0748)
- Necmettin Tanriover
- Serdar Sahin
- Ali Tunc
- Cansu Turker Saricoban
- Pinar Kadioglu
- Hande Mefkure Ozkaya
- Banu Betul Kocaman
Institutions
- Istanbul University-Cerrahpaşa (TR)
- Istanbul University (TR)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2026-03-08
- DOI
- https://doi.org/10.1111/cen.70121
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00